The fast track designation is supported by preclinical evidence of antitumor activity by ADCE-D01 in several STS tumor models ...
Japan's Sosei Group Corp said on Monday it is allying with a U.S. biotech run by former Novartis AG executives to commercialise a neurological drug pipeline.
Funded entirely by taxpayer dollars, this first-of-its-kind drug targets cellular metabolism to promote tissue repair of multiple organs.
DM1 cohort recruitment completion in Q4 2025, topline data in mid-2026, and potential BLA filing for z-basivarsen in late ...
The FDA approved Boehringer's nerandomilast, now Jascayd, as the first new U.S. treatment for idiopathic pulmonary fibrosis ...
Pfizer has re-entered the obesity drug sector by acquiring Metsera, Inc., having successfully outmaneuvered six other bidders ...
aeTranslational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier Université de Montpellier, Institut de Recherche pour le Développement, INSERM, Montpellier, France ...
Purpose of Study: The purpose of this study is to establish the safety and potential effectiveness of investigational FT819 in participants with moderate to severe systemic lupus erythematosus (SLE) ...
Persistent Link: https://ieeexplore.ieee.org/servlet/opac?punumber=8919 ...
NEW HAVEN, Conn.--(BUSINESS WIRE)--Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with ...
The Mists of Pandaria Classic story continues with both Alliance and Horde players able to complete daily quests in the Krasarang Wilds zone. Completing these quests grants reputation for Operation: ...
Diane Daugherty of Murrysville has been looking out her back window at a construction site for the past three years. She doesn’t think the developers should be starting a new project until they finish ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback